NEWS & UPDATES
Follow Our
Journey.
Explore media coverage, interviews, company announcements
and key developments as Core-Oli-T continues its journey from
scientific discovery to clinical impact.
News, Media & Company Updates
Latest Updates
This page brings together media coverage, interviews, company announcements and other developments related to Core-Oli-T.
Follow our progress as we advance antibody-based solutions for Parkinson’s disease diagnostics, imaging and future therapeutics.
● May 7, 2026
Core-Oli-T AB Receives Grant from TillväxtKronan – Coompanion
Core-Oli-T AB has been awarded a grant of 50 000 SEK from TillväxtKronan – Coompanion for the project “Early Diagnosis and Treatment of Parkinson’s Disease”. The decision was made by TillväxtKronan’s review committee during the spring 2026 funding round following an evaluation of applications from across the region. The funding will support the company’s continued work in early diagnostics and innovative strategies for Parkinson’s disease. We are very pleased and grateful for the confidence shown by TillväxtKronan.
“The support strengthens our ability to continue developing solutions that may contribute to early detection and improved treatment for patients living Parkinson’s disease”, says Björn CG Karlsson, CEO of Core-Oli-T AB.
The project is carried out with support from TillväxtKronan and Coompanion Kalmar Län.
● january 15, 2026
MedTechMagazine – Life Science Sweden presents Core-Oli-T AB as one of the most recently established biotech companies.
● October 28, 2025
The business incubator Kalmar Science Park welcomes Core-Oli-T AB
as a new member (ONLY AVAILABLE IN SWEDISH).
● August 11, 2025
Linnaeus Venture AB reports on a new strategic partnership and investment in the innovative start up Core-Oli-T AB.
● August 7, 2025
The Linnaeus University Promotes the winners of the 2024 Linnaeus University Innovation Call on Facebook.
● March 10, 2025
Core-Oli-T AB is registered as a company.